Takeda’s Dengue Vaccine Candidate Shows Promise ...Middle East

New Delhi:  Japanese pharma company Takeda on Friday announced that its dengue vaccine candidate, TAK-003, prevented 84 per cent of hospitalised dengue cases and 61 per cent of symptomatic cases. The 4.5-year-long phase-3 clinical trial, which included over 20,000 children and teenagers from South East Asia and Latin America, identified no “important safety risks”. The […] The post Takeda’s Dengue Vaccine Candidate Shows Promise appeared first on Ommcom News.

Hence then, the article about takeda s dengue vaccine candidate shows promise was published today ( Friday 10/06/2022 - 07:20 PM ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Takeda’s Dengue Vaccine Candidate Shows Promise )

Also on site :

• 7 Books To Read After 'Heated Rivalry,' According to a Librarian
• Living in the dark: Gaza’s struggle for electricity
• Macy's Has 'Incredibly Comfortable' and 'Stylish' Espadrilles for 40% Off, and You Can Wear Them for Hours